The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments
In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
The development comes as stroke remains one of the world’s biggest health threats
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Subscribe To Our Newsletter & Stay Updated
